In a yet another client win, Aagami received an assignment from an Innovative company who has developed an Abuse Deterrent and Life Saving Drug to add...
Published : 03 Aug 2018
Read MoreApart from promoting Aagami Inc, Dinesh Jain, the Founder CEO will be representing 2 clients at the The BIO International Convention 2018.The industry...
Published : 01 Jun 2018
Read MoreAagami Inc. has been appointed to support its new California based client’s Next-Generation PEG technology and assets with 53 Patents. The Tech...
Published : 10 May 2018
Read MoreHappy with the ongoing work, this existing Aagami client has given an additional assignment to Aagami. This time the assignment is to support the clie...
Published : 09 May 2018
Read MoreA US based company with consolidated annual sales of around US$700M has appointed Aagami to support their expansion in India, Middle East and other co...
Published : 07 Mar 2018
Read MoreIn a new assignment from a new client Aagami is now poised to support licensing or acquisition of the first and only oral contraceptive specifically d...
Published : 14 Feb 2018
Read MoreAagami received a renewal of annual contract for another year from its client.Client is an independent global Contract Research Organization (CRO) off...
Published : 27 Oct 2017
Read MoreIn September 2017, Aagami completed a busy and fruitful BioPharm America (BPA) 2017 conference with over 50 meetings. Dinesh Jain, CEO Aagami attended...
Published : 01 Oct 2017
Read MoreHappy with previous assignments delivered by Aagami, its Netherlands HQ'd client has given Aagami a broader and long term assignment, for partnering i...
Published : 20 Sep 2017
Read MoreAagami team are happy to anounced that their Louisiana based Biotechnology client have given another assignment (3rd from them) to sup...
Published : 08 Aug 2017
Read More